TM Holding Companies files Form D for $3.7 million offering
The Memphis-based biotechnology company reported selling the full amount to 62 investors under a Regulation D exemption.
TM Holding Companies, Inc. filed a Form D with the Securities and Exchange Commission disclosing an exempt securities offering. The issuer is a Delaware corporation incorporated in 2025, operating as TM Holding Companies, Inc.1 The company's principal place of business is listed at 51 Germantown Court, Suite 200, in Memphis, Tennessee.1
The filing classifies the issuer's industry as biotechnology within the health care sector.1
The offering relied on Rule 506(b) of Regulation D1 as its claimed exemption. The filing is a new notice, with a first sale date of 2026-08-10.1 The company indicated the offering is not intended to last more than one year.1
The total offering amount and total amount sold were both reported as $3,699,348, with $0 remaining to be sold.1 The filing states that 62 investors have already invested in the offering.1 The minimum investment accepted from any outside investor was listed as $0.1
The filing reported no sales commissions or finders' fees1 and no gross proceeds used for payments to executive officers, directors, or promoters1. The issuer declined to disclose its revenue range or aggregate net asset value.1
Related persons named in the filing include Alan Taylor, Sheryl Moroschak, Rebecca Wahl, and Dennis Long, each listed as executive officers and directors, along with Bruce Lawrence, listed as a director.1 The notice was signed by Alan Taylor, identified as CEO, with a signature date of 2026-10-05.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.